Clinical studies show a significant reduction in symptoms within just two weeks of nightly use.
The device applies targeted pressure to the cricoid cartilage to support upper esophageal sphincter (ues) function.
A mechanical therapeutic approach that provides a non-pharmacological and non-surgical option for managing symptoms.
Evaluated based on multi-center clinical study data assessing both safety and effectiveness in diagnosed lpr patients.
Backed by measurable outcomes with 92% of physicians reporting satisfaction with the device's clinical performance.

In clinical use, 86% of patients experienced a successful outcome with a significant reduction in symptoms after just two weeks of use.
Feedback from medical professionals supported device effectiveness, with 92% of physicians reporting satisfaction with the Reza Band.
The device provides a non-invasive option for symptom management, with 75% of patients reporting being satisfied or very satisfied with their results.
The device is worn externally and applies targeted pressure to support upper esophageal sphincter function, offering a drug-free and non-surgical option.
Designed to fit within established ENT and gastroenterology treatment pathways, the device is intended for use under medical supervision.